NCT04601909View on ClinicalTrials.gov

FX-322 in Adults With Age-Related Sensorineural Hearing Loss

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

May 16, 2022

Study Completion Date

May 16, 2022

Conditions
PresbycusisHearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Interventions
DRUG

FX-322

active comparator

OTHER

placebo

placebo

Trial Locations (5)

00000

Clinical Trial Site, Sarasota

Clinical Trial Site, Omaha

Clinical Trial Site, Amherst

Clinical Trial Site, San Antonio

Clinical Trial Site, Norfolk

Sponsors
All Listed Sponsors
lead

Frequency Therapeutics

INDUSTRY